New: NCI-funded clinical trial search
Mednet Logo
CommunityEndocrinology

Endocrinology

Physician discussions on diabetes management, thyroid disorders, hormonal imbalances, and metabolic conditions.

Recent Discussions

When do you recommend plasmapheresis/plasma exchange for management of severe hypertriglyceridemia?

2 Answers

Mednet MemberInvited Expert
Endocrinology · Medical University of South Carolina College of Medicine

Generally, I recommend plasmapheresis for severe hypertriglyceridemia when patients are admitted with acute pancreatitis who either do not respond to NPO (and/or insulin if they have hyperglycemia) or if they are critically ill with for example necrotizing pancreatitis. Triglyceride concentrations d...

How do you manage antipsychotic-induced prolactinemia?

7
1 Answers

Mednet Member
Psychiatry · Massachusetts General Hospital/Harvard Medical School

Most patients treated with standard doses of risperidone and paliperidone will develop hyperprolactinemia, typically below 100 ng/ml. However, not all individuals with elevated prolactin levels will exhibit clinical symptoms such as erectile dysfunction, galactorrhea, or irregular/absent menstrual c...

Is it safe to continue administering Prolia per schedule for osteoporosis treatment shortly after a patient has undergone extensive spinal surgery?

1
2 Answers

Mednet Member
Endocrinology · Providence John Wayne Cancer Institute Endocrinology

There is no evidence that spine surgery is a contraindication to receiving Prolia. If the bone was incised, Prolia could help healing.

About Mednet

A community where doctors find answers to medicine's toughest questions.

  • Verified, credentialed physicians
  • 45,000+ members across 24 specialties
  • Free CME and MOC credit

What patient-specific factors would influence your decision to initiate semaglutide therapy in patients with HIV-associated lipohypertrophy?

1
1 Answers

Mednet Member
Infectious Disease · UT Southwestern

I would consider it if the patient had diabetes. But there is not much data on this question.

Is it possible for certain individuals with osteoporosis to be a denosumab "non-responder"?

1 Answers

Mednet MemberInvited Expert
Endocrinology · Milwaukee Va Medical Center

As far as I know, there are non-responders to every drug. There are 2 considerations that you should particularly consider, and which you could address. First, does the patient have an unrecognized secondary cause for low bone mass or fracture? It is really important to reevaluate a patient who is n...

Would you order a fibroscan to screen for MASLD in patients with insulin resistance but normal LFTs?

1 Answers

Mednet MemberInvited Expert
Endocrinology · University of Missouri School of Medicine

Suggest that you check the FIB-4 score first.

Can combined oral contraceptive use cause falsely elevated 24-hour urine-free cortisol?

1
2 Answers

Mednet MemberInvited Expert
Endocrinology · Johns Hopkins Endocrinology and Pituitary Center

UFC is an expression of free cortisol. It should not be affected by oral estrogen.

How long should T3 be continued in hypothyroid patients who received no symptomatic benefit after starting T3/T4 combination therapy?

2
2 Answers

Mednet Member
Endocrinology · Endocrinology Clinics Of Texas

I stop at next visit and increase T4 replacement accordingly.

Does the presence of osteoporosis change the extent of workup that should be performed for an older patient with otherwise serologically low-risk MGUS?

1
1 Answers

Mednet MemberInvited Expert
Medical Oncology · University of Washington, Fred Hutchinson Cancer Research Center

In brief - no, it shouldn't. While some previous studies have suggested that patients with MGUS are more likely to develop osteoporosis than those who don't, this is often related to confounders when MGUS is picked up clinically - in other words, patients with comorbidities that prompt a doctor to l...

Would elevated bone mineral density/T-score be enough to make a diagnosis of osteopetrosis?

1 Answers

Mednet MemberInvited Expert
Endocrinology · Boston University School of Medicine

You should not make the diagnosis of osteopetrosis based on a high bone density. There are several causes for high bone density including the autosomal recessive genetic disorder sclerostosis which is caused by mutations in the STOST gene which prevents the production of functional sclerostin.